Antimicrobial Resistance Spectrum Conferred by pRErm46 of Emerging Macrolide (Multidrug)-Resistant Rhodococcus equi
Erdal Erol, Mariela Scortti, Jordan Fortner, Mukesh Patel, José A. Vázquez‐Boland
Abstract
Clonal multidrug resistance recently emerged in Rhodococcus equi , complicating the therapeutic management of this difficult-to-treat animal- and human-pathogenic actinomycete. The currently spreading multidrug-resistant (MDR) “2287” clone arose in equine farms upon acquisition, and coselection by mass macrolide-rifampin therapy, of the pRErm46 plasmid carrying the erm (46) macrolide-lincosamide-streptogramin resistance determinant and of an rpoB S531F mutation.
Topics & Concepts
MicrobiologyBiologyRhodococcus equiMultiple drug resistanceAmikacinVirologyCefoxitinIntegronDrug resistanceAntibiotic resistanceAntimicrobialStaphylococcus aureusAntibioticsGeneticsBacteriaVirulenceGeneInfectious Disease Case Reports and TreatmentsBiliary and Gastrointestinal FistulasInfections and bacterial resistance